NCT00602966 Oocyte Cryopreservation: Slow Cooling Versus Vitrification Techniques on Oocyte Survival Status COMPLETED Phase N/A
NCT00595413 Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II) Status COMPLETED Phase PHASE2
NCT00590824 Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00575302 Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age Status WITHDRAWN Phase PHASE4
NCT00573157 The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis Status TERMINATED Phase PHASE2/PHASE3
NCT00430495 A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I) Status COMPLETED Phase PHASE2
NCT00409188 Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) Status COMPLETED Phase PHASE3
NCT00408967 Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression. Status WITHDRAWN Phase PHASE2
NCT00407472 ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency Status COMPLETED Phase PHASE1
NCT00328926 Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L]) Status TERMINATED Phase PHASE4
NCT00314288 Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia Status COMPLETED Phase PHASE2
NCT00304291 A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) Status COMPLETED Phase PHASE4
NCT00304252 Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease Status TERMINATED Phase PHASE2
NCT00303381 Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis Status COMPLETED Phase PHASE2